title: Effect of oral anticoagulant therapy on fibrinolysis parameters in chronic non-rheumatic atrial fibrillation.
authors.forename: V
authors.initials: V
authors.lastname: Roldán-Schilling
authors.forename: F
authors.initials: F
authors.lastname: Marín-Ortuño
authors.forename: P
authors.initials: P
authors.lastname: Marco-Vera
authors.forename: F
authors.initials: F
authors.lastname: Sogorb-Garri
mesh_terms: D000074:Acenocoumarol / Q000008:administration & dosage / Q000494:pharmacology; D000284:Administration, Oral; D000368:Aged; D000925:Anticoagulants / Q000494:pharmacology* / Q000627:therapeutic use; D000933:Antifibrinolytic Agents; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001779:Blood Coagulation Factors / Q000187:drug effects; D002908:Chronic Disease; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000187:drug effects; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D; D000074:Acenocoumarol